MedAssets (MDAS +1.8%) moves up on an upgrade to Buy at UBS, saying the company's RCM segment growth will accelerate, and when combined with SCM execution it should drive shares higher. The firm raises its price target to $18 from $14.
MedAssets (MDAS +1.8%) moves up on an upgrade to Buy at UBS, saying the company's RCM segment...
From other sites
Video at CNBC.com (Oct 31, 2013)
Video at CNBC.com (Oct 3, 2013)
at CNBC.com (Oct 27, 2011)
at CNBC.com (Mar 26, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs